TABD Innovation Conference Healthcare

8 May 2007 Berlin, Germany
This event is organised by the Trans Atlantic Business Dialogue (TABD) and is supported by the EU Commission and the US Department of Commerce. The underlying factors creating common challenges in Healthcare on both sides of the Atlantic range from demographics to pandemics or chronical diseases, to name but a few. This event aims to focus on the role and contribution that innovation and transatlantic innovation policies can play in addressing these challenges. The conference will bring together leaders from the private sector, academia and governments with a direct interest in the creation and use of innovation in Healthcare with a view to develop new thinking and show new cooperative ways on how to face and address these challenges. Concrete recommendations summarizing the results of these discussions should inform and guide future policy decision by the EU and US governments in this area.

TABD Mission Statement
For nearly 60 years, the transatlantic relationship has drawn its strength and durability from many different forms of partnership, notably in the political, economic and security areas.

The Transatlantic Business Dialogue (TABD) - which is the key interlocutor with government on the transatlantic economic relationship - has been renewed under fresh leadership and with a 30-strong business advisory board consisting of CEOs from companies across a range of business sectors in the EU and the US. This will bring a changed focus as well as another source of energy for the economic partnership in its own right, while also recognising the need to ensure that the economic, political and security relationship is rooted in an awareness of our common interests and values.

A strong transatlantic relationship enhances the capacity of the US and the EU to jointly influence global developments for the benefit of all countries, whatever their stage of development.

The TABD believes that neither side should take transatlantic economic ties for granted and that both should work harder to avoid the periodic regulatory and trade conflicts that trouble the relationship. But the economic agenda must look beyond conflict avoidance and management to develop joint responses to common global challenges. We shall play our part in pro-actively identifying those challenges and recommending appropriate responses through well-informed policy advice based on positions determined through the direct participation of our member companies chief executives.

For further information, please visit:

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...